您的位置: 首页 > 农业专利 > 详情页

MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
专利权人:
The General Hospital Corporation
发明人:
Rakesh K. Jain,Dai Fukumura,Satoshi Kashiwagi
申请号:
US13693692
公开号:
US20130195926A1
申请日:
2012.12.04
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The instant invention provides methods for treating a solid tumor in a subject comprising modulating nitric oxide production in the tumor to normalize tumor vasculature and administering an anti-tumor therapy to the subject. The invention further provides methods of treating a solid tumor in a subject comprising selectively increasing cyclic guanosine monophosphate (cGMP) or cGMP dependent protein kinase G production in the tumor vasculature to an amount effective to normalize tumor vasculature and administering an anti-tumor therapy to the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充